Apogee Therapeutics, Inc. 4 SEC Filings

Filed On	Filing
03 Sep 2026	Form 4: Fairmount Funds Management Llc, Director and 3 others Returned 443,187 shares to the issuer · Disposed of 6,743,321 Non-Voting Common Stock (Disposition to Issuer) · Disposed of 80,246 Stock Option (Right to Buy) (Disposition to Issuer)
03 Sep 2026	Form 4: McKenna Mark C., Director Returned 20,000 shares to the issuer · Disposed of 182,488 Stock Option (Right to Buy) (Disposition to Issuer)
03 Sep 2026	Form 4: Jones William A Jr, Director Returned 34,824 shares to the issuer · Disposed of 32,488 Stock Option (Right to Buy) (Disposition to Issuer)
03 Sep 2026	Form 4: Dambkowski Carl, Chief Medical Officer Returned 1,375 shares to the issuer ($186K) · Returned 167,123 shares to the issuer · Disposed of 319,317 Stock Option (Right to Buy) (Disposition to Issuer)
03 Sep 2026	Form 4: Fox Jennifer A., Director Returned 34,824 shares to the issuer · Disposed of 32,488 Stock Option (Right to Buy) (Disposition to Issuer)
03 Sep 2026	Form 4: Henderson Jane, Chief Financial Officer Returned 158,371 shares to the issuer · Disposed of 383,997 Stock Option (Right to Buy) (Disposition to Issuer)
03 Sep 2026	Form 4: Bollinger Lisa, Director Disposed of 48,780 Stock Option (Right to Buy) (Disposition to Issuer)
03 Sep 2026	Form 4: Henderson Michael Thomas, Director Returned 920,941 shares to the issuer · Disposed of 997,064 Stock Option (Right to Buy) (Disposition to Issuer)
03 Sep 2026	Form 4: Shah Nimish P, Director Returned 1,750,000 shares to the issuer ($236M) · Disposed of 6,743,321 Non-Voting Common Stock (Disposition to Issuer) ($911M) · Disposed of 80,246 Stock Option (Right to Buy) (Disposition to Issuer) · 1 more
11 Aug 2026	Form 4: Fairmount Funds Management Llc, Director and 3 others Received 42,208 shares by exercise or conversion ($996K)
07 Aug 2026	Form 4: Dambkowski Carl, Chief Medical Officer Received 4,125 shares by exercise or conversion ($94.3K) · Sold 5,500 shares ($738K)
24 Jul 2026	Form 4: Henderson Jane, Chief Financial Officer Gave 15,000 shares as a gift
16 Jul 2026	Form 4: Dambkowski Carl, Chief Medical Officer Gave 8,000 shares as a gift
10 Jul 2026	Form 4: Henderson Michael Thomas, Director Sold 20,000 shares ($2.67M) · Gave 75,046 shares as a gift
02 Jul 2026	Form 4: Dambkowski Carl, Chief Medical Officer Received 4,125 shares by exercise or conversion ($94.3K) · Sold 5,500 shares ($730K)
24 Jun 2026	Form 4: Dambkowski Carl, Chief Medical Officer Sold 26,400 shares ($3.5M)
24 Jun 2026	Form 4: Henderson Michael Thomas, Director Sold 80,000 shares ($10.6M)
12 Jun 2026	Form 4: Henderson Michael Thomas, Director Sold 20,000 shares ($1.67M)
11 Jun 2026	Form 4: Fairmount Funds Management Llc, Director and 1 other Granted 7,657 Stock Option (Right to Buy)
11 Jun 2026	Form 4: Shah Nimish P, Director Granted 7,657 Stock Option (Right to Buy)

Comments